Abstract

The mouse genome sequence has been examined to identify the complete set of proteins related to the human glycanbinding receptor, DC-SIGN. In addition to five SIGNR proteins previously described, a pseudogene, encoding a hypothetical SIGNR6, and a further two expressed proteins, SIGNR7 and SIGNR8, have been identified. The ligand-binding properties of these novel proteins and of the previously described mouse SIGNs have been systematically investigated in order to define the mouse proteins that most resemble human DC-SIGN and DC-SIGNR. Results from screening of a glycan array demonstrate that only mouse SIGNR3 shares with human DC-SIGN the ability to bind both high mannose and fucose-terminated glycans in this format and to mediate endocytosis. The finding that neither SIGNR1 nor SIGNR5 binds with high affinity to specific ligands in a large panel of mammalian glycans is consistent with the suggestion that these receptors bind surface polysaccharides on bacterial and fungal pathogens in a manner analogous to serum mannose-binding protein. The data also reveal that two of the mouse SIGNs have unusual binding specificities that have not been previously described for members of the C-type lectin family; the newly identified SIGNR7 binds preferentially to the 6-sulfo-sialyl Lewis(x) oligosaccharide, whereas SIGNR2 binds almost exclusively to glycans that bear terminal GlcNAc residues. The results presented demonstrate that the mouse homologs of DC-SIGN have a diverse set of ligand-binding and intracellular trafficking properties, some of which are distinct from the properties of any of the human receptors.

Highlights

  • The human receptor designated as the dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN)4 has been identified both as an adhesion mol

  • Sequence Comparisons of Mouse SIGNs—Potential mouse orthologs of human DC-SIGN were previously identified by JULY 21, 2006

  • The genomic analysis presented here defines the full set of mouse homologs of human DC-SIGN, but the results shown in Figs. 3 and 5 indicate that sequence comparison alone is not sufficient to suggest that one of these proteins is a specific ortholog

Read more

Summary

EXPERIMENTAL PROCEDURES

Data Base Screening—The Ensembl annotation of the mouse genome was screened with InterPro profile IPR001304 to identify genes containing potential C-type CRDs. Additional binding assays with fluorescein-labeled, glycosylated polyacrylamide polymers (GlycoTech) were performed in the same format and read on a Victor plate reader from PerkinElmer Life Sciences In these studies, the buffer was 150 mM NaCl, 25 mM Tris-Cl, pH 7.4, 2 mM CaCl2, with 1% BSA present during ligand binding. For probing of the glycan array, tetramerized proteins were labeled with fluorescein isothiocyanate [9] following dialysis into 1.25 M NaCl, 25 mM Na-HEPES, pH 8.0, 25 mM CaCl2 or after repurification on a mannose-Sepharose column that was rinsed with buffer containing 1.25 M NaCl, 25 mM Bicine-Cl, pH 9.0, and 25 mM CaCl2 and eluted with 1.25 M NaCl, 25 mM Bicine-Cl, pH 9.0, and 2.5 mM EDTA. Protein expression was verified by Western blotting with antibodies to the bacterially expressed extracellular domain, raised in sheep

RESULTS
Binding properties of human and mouse SIGNs
Undiluted Undiluted
Further insights into the binding characteristics of the mouse
DISCUSSION
Binding to Lewisx
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call